- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Insulin Degludec
Total 8009 results
-
Hennepin Healthcare Research InstituteTerminatedDiabetes MellitusUnited States
-
Novo Nordisk A/SCompleted
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesJapan
-
Novo Nordisk A/SCompletedDiabetes | Type 2 Diabetes MellitusGermany
-
Eli Lilly and CompanyCompletedType 2 Diabetes MellitusUnited States, Puerto Rico, Mexico
-
Mountain Diabetes and Endocrine CenterNovo Nordisk A/SCompletedType1 Diabetes MellitusUnited States
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2Malaysia, South Africa, Philippines, Australia, India, Saudi Arabia
-
Ain Shams UniversityUnknownType 1 Diabetes Mellitus With Hypoglycemia | type1diabetesEgypt
-
Kirsten NørgaardUnknown
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2United States, Slovakia, Canada, South Africa, Puerto Rico, Poland
-
Tulane University Health Sciences CenterCompleted
-
University of Split, School of MedicinePavle Vrebalov Cindro; Jonatan Vuković; Darko Modun; Božo Smajić; Gordan Kardum; Tina... and other collaboratorsCompletedInsulin Glargine U300 vs Insulin Degludec U100 in Impact on the Glycaemic and Cardiovascular FactorsDiabetes Mellitus, Type 2Croatia
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Japan
-
Mountain Diabetes and Endocrine CenterUnknownType 1 Diabetes MellitusUnited States
-
University of GuadalajaraCompletedType 2 Diabetes MellitusMexico
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, India, Canada, Spain, Switzerland, Argentina, Finland, Hungary, Russian Federation, Slovenia, Slovakia
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1Japan
-
GeropharmCompletedDiabetes | Diabetes Mellitus, Type 1Russian Federation
-
Weill Cornell Medical College in QatarNovo Nordisk A/STerminated
-
Wake Forest University Health SciencesNational Institute on Aging (NIA); General ElectricCompletedMild Cognitive Impairment | Alzheimer's DiseaseUnited States
-
Eli Lilly and CompanyCompletedType 1 Diabetes MellitusItaly, Japan, United States, Puerto Rico, Spain, Taiwan, Mexico, Austria, Germany, Poland, New Zealand, Romania, Russian Federation, Argentina, India, Sweden, Slovakia, Australia, Brazil, Greece
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 1Germany
-
Novo Nordisk A/SCompleted
-
GeropharmUnknownEfficacy and Safety of GP40081 Сompared to NovoMix® 30 FlexPen® in Type 2 Diabetes Mellitus PatientsDiabetes Mellitus, Type 2 | Diabetes MellitusRussian Federation
-
Diasome PharmaceuticalsCompletedDiabetes Mellitus, Type 1United States
-
Eli Lilly and CompanyCompletedType 2 Diabetes MellitusUnited States, Hungary, Puerto Rico, Spain, Australia, Korea, Republic of, Mexico, Japan, Germany, Russian Federation, Taiwan, Slovakia, Argentina, Czechia, India, Italy
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesHong Kong, China
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 1Germany
-
GlookoCompletedType 2 Diabetes MellitusUnited States
-
Novo Nordisk A/SCompleted
-
Novo Nordisk A/SCompleted
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1Canada
-
GeropharmCompletedClamp StudyRussian Federation
-
GeropharmCompletedClamp StudyRussian Federation
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, India, Italy, Mexico, Poland, Russian Federation, Slovakia, United Kingdom, Argentina, Norway, Turkey, Israel, Czechia, South Africa, Hungary, Brazil
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1United States, Russian Federation, United Kingdom, Canada, France, Netherlands, Belgium, Germany, Slovenia
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesChina
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, India, Russian Federation, Serbia, Turkey, Algeria, Czechia
-
University of Texas Southwestern Medical CenterCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States
-
Novo Nordisk A/SCompleted
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1Switzerland, Denmark, Germany, Italy, Netherlands, Spain, Sweden, United Kingdom
-
University Hospital Inselspital, BerneCompletedDiabetes Complications | Type 1 Diabetes MellitusSwitzerland
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Poland, India, Italy, Mexico, Russian Federation, United Kingdom, Spain, Malaysia, Croatia, Greece, Korea, Republic of, Japan, South Africa, Algeria, Thailand, Argentina, Brazil, Canada, Romania
-
Nordsjaellands HospitalOdense University Hospital; Zealand University Hospital; Aarhus University Hospital and other collaboratorsCompletedType 1 Diabetes Mellitus | Nocturnal Hypoglycemia | Recurrent Severe HypoglycaemiaDenmark
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1Germany
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1Germany, France, United States, Japan, Netherlands, Russian Federation, Bulgaria, United Kingdom, North Macedonia, South Africa, Italy, Finland
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1United States, Poland, Finland, Belgium, Hungary, United Kingdom, Germany, Canada, Czechia
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1United States, India, Israel, Italy, Japan, Russian Federation, Canada, Austria, Taiwan, Serbia, Germany, Bulgaria, Puerto Rico
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1United States, India, Russian Federation, Belgium, Spain, Israel, Croatia, Serbia, North Macedonia, South Africa, Slovenia, Brazil, Poland, Canada, Czechia